Chemical injection controller

The novel structure of a separate active member and push operation member with a coil spring mechanism addresses the challenges of dimensional stability and precision in drug solution injection controllers, ensuring stable and accurate rapid drug administration in a compact form.

JP7579523B2Active Publication Date: 2024-11-08NIPRO CORP
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
JP2022188003
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-11-25
Publication Date
2024-11-08
Estimated Expiration
2039-03-13

AI Technical Summary

Technical Problem

Existing drug solution injection controllers face challenges in maintaining dimensional stability and precision due to elongated active members, which affect the symmetry and movement accuracy, especially when miniaturization is required for wearable devices.

Method used

A novel structure featuring a separate active member and push operation member, with a coil spring and return spring mechanism, allows for stable operation and precise control of the valve body, reducing the need for elongated components and improving movement accuracy.

Benefits of technology

The separate active member and push operation design enhances the stability and accuracy of the valve operation, enabling reliable and rapid drug administration while maintaining a compact size.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007579523000001
    Figure 0007579523000001
  • Figure 0007579523000002
    Figure 0007579523000002
  • Figure 0007579523000003
    Figure 0007579523000003
Patent Text Reader

Abstract

A liquid medicine injection controller with a novel structure is provided, which makes it easy to arrange a pressing operation member and a driving member at predetermined positions and realizes stable operation of a valve body for rapid administration. [Solution] A liquid medicine injection controller (10) that can perform rapid injection of a liquid medicine by self-operation, in which a pressing operation member (52) that performs rapid injection of the liquid medicine is assembled so as to be able to move back and forth in a housing (12) that accommodates a sub-reservoir (14). A valve body (72) for rapid injection that switches the outflow flow path (64) between a connected state and a blocked state is provided on an outflow flow path (64) for the liquid medicine from the sub-reservoir (14). A driving member (90) that is separate from the pressing operation member (52) and the valve body (72) is disposed across a gap (118) from the pressing operation member (52) that is in a preparation position before being pressed. The driving member (90) is moved when the pressing operation member (52) comes into contact with the driving member (90) when pressed, and moves the valve body (72) so as to change the outflow flow path (64) from a blocked state to a connected state.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a liquid medicine injection controller that enables a liquid medicine administration device that performs continuous administration of a liquid medicine to perform rapid injection of the liquid medicine by a user's own operation. [Background technology]

[0002] Conventionally, a drug solution administration device that continuously administers a drug solution has been known, and is used, for example, when administering a painkiller or an anesthetic into the body in small amounts. In addition, the drug solution administration device may include a drug solution injection controller that allows the patient to perform rapid administration of the drug solution by self-operation. The drug solution injection controller includes a sub-reservoir that stores the drug solution, and when the patient performs a self-operation, such as by pressing a pressing member, the drug solution stored in the sub-reservoir of the drug solution injection controller is rapidly administered into the patient's body through a sub-line branched off from a main line. Summary of the Invention [Problem to be solved by the invention]

[0003] The liquid medicine injection controller is provided with a mechanism for opening the outflow passage connected to the sub-reservoir to allow the liquid medicine to flow out of the sub-reservoir when operated by the patient himself / herself. For example, when the patient presses the pressing operation member, the driving member integrally formed with the pressing operation member presses the valve body for rapid administration, thereby moving the valve body in a direction away from the outflow passage.

[0004] However, if the driving member is extended to the vicinity of the valve body so that the driving member operates the valve body, the driving member extending from the pressing operation member becomes long, and the length dimension of the pressing operation member becomes large only at the portion where the driving member is formed, so that the shape symmetry is greatly impaired and it is difficult to stabilize the dimensional accuracy. By shortening the driving member, the dimensional accuracy can be improved, but the movement stroke of the driving member becomes long, and minute dimensional errors affect the movement of the driving member. In addition, since the liquid injection controller is always worn and used, it is required to be compact, but the miniaturization of each component constituting the liquid injection controller requires each component to have high operating accuracy.

[0005] An object of the present invention is to provide a liquid injection controller having a novel structure that can improve the movement stability of a driving member. [Means for solving the problem]

[0006] The following describes preferred embodiments for understanding the present invention, but the embodiments described below are merely illustrative and may be combined with one another as appropriate, and the multiple components described in each embodiment may be recognized and used independently as far as possible, and may also be combined with any of the components described in another embodiment as appropriate. As a result, the present invention is not limited to the embodiments described below, and various other embodiments may be realized.

[0007] The first aspect of the present invention is A cup-shaped container having a peripheral wall and a bottom. A pressing member for performing rapid drug solution administration is assembled so as to be capable of reciprocating movement in a housing that accommodates a sub-reservoir, and a plunger is provided that is actuated via a spring when the pressing member is pressed to press the sub-reservoir, and the plunger presses the sub-reservoir. The above The plunger is positioned so as to overlap with the bottom, and a mark is provided on the plunger to make the position of the plunger in the reciprocating direction visible from the outside of the housing. The peripheral wall and the bottom of the sub-reservoir are made of a single material, including a protrusion formed on the bottom for positioning the plunger. It is something. A second aspect of the present invention is the liquid injection controller according to the first aspect, The above Positioning For The protrusion is fitted into a fitting hole formed in the plunger to be positioned, and a coil spring is disposed between the pressing operation member and the plunger, and one end of the coil spring abutting against the plunger is fitted into the fitting hole of the plunger. For The protrusion is located so as to protrude from the inner periphery of the coil spring. A third aspect of the present invention is a drug solution injection controller according to the first or second aspect, wherein the bottom of the sub-reservoir is thicker than the peripheral wall of the sub-reservoir, and when the pressing operation member is pressed, the bottom of the sub-reservoir is maintained in an overlapping state with the plunger, and the central portion of the bottom of the sub-reservoir is curved convexly toward the inside of the sub-reservoir. A fourth aspect of the present invention is a liquid injection controller according to any one of the first to third aspects, The above Positioning For The protrusion is fitted into a fitting hole formed in the plunger to be positioned, and the positioning For The protrusion has a tapered tip end and a step formed on the base end side of the tapered tip, the step being engaged with the fitting hole. In addition, in a first aspect of the invention related to the parent application, a pressing operation member for performing rapid administration of medicinal liquid is assembled so as to be able to move back and forth in a housing which contains a sub-reservoir, and a valve body for rapid administration which switches the outflow flow path from the sub-reservoir between a connected state and a blocked state is provided on the outflow flow path of the medicinal liquid, and a main moving member which is separate from the pressing operation member and the valve body is arranged across a gap from the pressing operation member which is in a preparation position before being pressed, and when the pressing operation member is pressed and brought into contact with the main moving member, the main moving member moves the valve body so as to change the outflow flow path from a blocked state to a connected state.

[0008] According to the liquid injection controller constructed according to this embodiment, the driving member that moves the valve body for rapid administration to a position where the outflow flow path is in communication when the pressing member is operated is separate from both the pressing member and the valve body, so that neither the driving member nor the pressing member need to be long parts. Therefore, the dimensional stability of each member, such as the driving member and the pressing member, is improved. In addition, since the pressing member and the driving member are separated, the moving stroke of the driving member can be set short. As a result, the moving stability of the driving member and the operating accuracy of the member are improved.

[0009] Furthermore, since there is no need for the main driving member and the pressing operation member to be long parts, for example, the main driving member and the pressing operation member are less likely to undergo dimensional changes due to bending, and the pressing operation member can stably open and close the valve body by pressing the rapid administration valve body via the main driving member.

[0010] Furthermore, the driving member is disposed with a gap between it and the pressing operation member, which is in the preparation position before the pressing operation. Therefore, when the pressing operation member comes into contact with the driving member, an impact is generated, and this impact is transmitted to the fingers of the patient operating the pressing operation member. Therefore, the patient operating the pressing operation member can grasp the amount of operation of the pressing operation member by the tactile response.

[0011] of the invention related to the parent application The second aspect is of the invention related to the parent application In the drug solution injection controller described in the first aspect, the driving member is arranged with a gap between the pressing operation member which is in a preparation position before the pressing operation and the valve body which is in a blocking position of the outflow flow path.

[0012] With a drug solution injection controller constructed according to this aspect, even when the driving member pushed in by the pressing member comes into contact with the valve body for rapid administration, the impact of the contact is transmitted to the fingers of the patient operating the pressing member, etc. Therefore, the patient operating the pressing member can know, for example, from a tactile response that the driving member has been pushed in to a position that will move the valve body.

[0013] of the invention related to the parent application The third aspect is of the invention related to the parent application In the drug solution injection controller described in the first or second aspect, a return spring is provided which exerts a spring force on the driving member moved by the contact of the pressing operation member in a direction returning the driving member to its initial position before it was moved.

[0014] In a liquid injection controller constructed according to this aspect, the driven member moved by the contact of the pressing member is biased by the return spring in a direction returning it to its initial position before being moved. As a result, when the pressing of the driven member by the pressing member is released, the biasing force of the return spring causes the driven member to quickly separate from the rapid administration valve body, and the force applied from the driven member to the valve body is more reliably released. As a result, the rapid administration valve body can more reliably switch the outflow flow path from a connected state to a blocked state.

[0015] of the invention related to the parent application The fourth aspect is of the invention related to the parent application In the chemical liquid injection controller according to a third aspect, the return spring is integrally formed with the driving member.

[0016] According to the chemical liquid injection controller constructed according to this embodiment, the return spring is integrally formed with the driving member, thereby making it possible to reduce the number of parts.

[0017] of the invention related to the parent application The fifth aspect is of the invention related to the parent application In the liquid injection controller according to any one of the first to fourth aspects, the driven member moves in the same direction as the reciprocating direction of the pressing operation member.

[0018] According to a liquid injection controller constructed according to this aspect, the liquid injection controller can be made smaller in size in the direction perpendicular to the direction of reciprocating movement of the pressing operation member.

[0019] of the invention related to the parent application The sixth aspect is of the invention related to the parent application In the drug solution injection controller described in any one of the first to fifth aspects, the post-contact movement stroke amount of the pressing operation member after the pressing operation member contacts the driven member is 1 / 5 or less of the total movement stroke amount of the pressing operation member by a pressing operation to perform rapid drug solution administration.

[0020] With a drug solution injection controller constructed according to this embodiment, the tactile response transmitted to the patient by the contact between the pressing operation member and the driven member occurs at the end of the stroke of the pressing operation member, so the patient can understand from the tactile response that the movement of the pressing operation member will soon be completed. Moreover, the time from when the patient feels the tactile response to when the pressing operation is completed is sufficiently short, so that the patient can be notified at an appropriate time that the pressing movement of the pressing operation member will soon be completed. Effect of the Invention

[0021] According to the present invention, the pushing operation member and the driving member can be easily arranged in the predetermined positions, and stable operation of the valve body for rapid administration can be achieved. [Brief description of the drawings]

[0022] [Figure 1] FIG. 1 is a perspective view showing a chemical liquid injection controller according to a first embodiment of the present invention; [Diagram 2] FIG. 2 is a perspective view showing the liquid injection controller shown in FIG. 1 with the upper half of the housing removed; [Diagram 3] FIG. 3 is a cross-sectional view of the liquid injection controller shown in FIG. 1, which corresponds to the cross section of FIG. 4 along line III-III. [Figure 4] IV-IV cross section of Figure 3 [Diagram 5] VV cross section of Figure 3 [Figure 6] VI-VI cross section of Figure 3 [Figure 7] Cross-sectional view of FIG. 3 taken along the line VII-VII [Figure 8] FIG. 2 is a perspective view of a driving member constituting the liquid injection controller shown in FIG. [Figure 9] FIG. 9 is a perspective view showing the driving member of FIG. 8 from a different angle. [Figure 10] 12 is a cross-sectional view showing a preparation state after priming is completed in the liquid injection controller shown in FIG. 3; [Figure 11] XI-XI cross section of Figure 10 [Figure 12] Sectional view of XII-XII in Fig. 10 [Figure 13] XIII-XIII sectional view of Figure 10 [Figure 14] 14 is a cross-sectional view showing a state in which a push button is pressed in the liquid injection controller shown in FIG. 3, and corresponds to the cross-section XIV-XIV in FIG. 15. [Figure 15] XV-XV cross section of Figure 14 [Figure 16] Sectional view XVI-XVI of Fig. 14 [Figure 17] FIG. 4 is a cross-sectional view showing a state in which rapid drug injection has been completed in the drug injection controller shown in FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0023] Hereinafter, an embodiment of the present invention will be described with reference to the drawings.

[0024] FIG. 1 shows a liquid medicine injection controller 10 according to a first embodiment of the present invention. The liquid medicine injection controller 10 is for a patient, who is a user, to perform rapid liquid medicine administration by self-operation, and has a structure in which a sub-reservoir 14 is housed and incorporated in a housing 12, as shown in FIGS. 2 to 7. In order to make the internal structure of the liquid medicine injection controller 10 easier to see, the upper half of the housing 12 is not shown in FIG. 2. In the following description of the liquid medicine injection controller 10, the up-down direction generally refers to the left-right direction in FIG. 4, the front-rear direction refers to the up-down direction in FIG. 3, which is the axial direction, and the left-right direction refers to the left-right direction in FIG. 3.

[0025] More specifically, the housing 12 is formed of a hard synthetic resin or the like. The housing 12 is generally hollow and elongated in the front-rear direction, more specifically, substantially cylindrical with a bottom. The housing 12 has a flat hollow cross-sectional shape over a wide range except for the rear end portion, and in this embodiment, has a hollow substantially elliptical cross-sectional shape. As a result, the long axis direction, which is the longitudinal direction of the cross section of the housing 12, is the up-down direction, and the short axis direction is the left-right direction. The flat cross-sectional shape referred to here is not limited to an elliptical cross-sectional shape, and may be, for example, a flat polygonal cross-sectional shape. Preferably, the housing 12 has an outer diameter dimension that allows the patient to hold it with one hand, and the outer circumferential surface is provided with a gripping surface 16 that is gripped by the patient.

[0026] Further, a sub-reservoir 14 is accommodated in the housing 12. The sub-reservoir 14 is configured by covering the opening of a cup-shaped diaphragm portion 18 with a base member 20, as shown in Figs.

[0027] The diaphragm portion 18 is made of rubber, resin elastomer, or the like, and has flexibility. The diaphragm portion 18 is generally cup-shaped when left stationary with no external force acting thereon. A flange-shaped clamping portion 22 that protrudes to the outer periphery is integrally formed around the entire periphery of the opening of the diaphragm portion 18. A bottom portion 24 of the diaphragm portion 18 is thicker than the peripheral wall portion of the diaphragm portion 18, and has high deformation rigidity.

[0028] The front surface of the inner periphery of the bottom 24 of the diaphragm portion 18 is a curved surface with a spherical crown shape. Also, the curvature of the front surface of the spherical crown-shaped protruding portion of the bottom 24 of the diaphragm portion 18 is made smaller than the curvature of the concave surface that constitutes the rear surface of the base member 20. This reduces the amount of drug solution remaining in the sub-reservoir 14 in the contracted state, and makes it difficult for the bottom 24 of the diaphragm portion 18 to stick to the rear surface of the base member 20.

[0029] The bottom 24 of the diaphragm portion 18 has a protruding portion protruding rearward from the center. It is a protrusion for positioning. The positioning protrusion 26 is integrally formed. The positioning protrusion 26 is rod-shaped, and has a tapered portion 28 whose tip portion becomes smaller in diameter toward the tip. The large-diameter end of the tapered portion 28 has a larger diameter than the base end of the positioning protrusion 26 outside the tapered portion 28, forming a step.

[0030] The base member 20 is made of a hard synthetic resin or the like and has a generally circular disk shape. A cylindrical liquid medicine inlet portion 30 and a liquid medicine outlet portion 32 are formed penetrating the base member 20. A plurality of engagement protrusions 34 protrude rearward (upward in FIG. 7) from the base member 20. The base member 20 is connected to a guide member 36 by the engagement protrusions 34.

[0031] The guide member 36 is formed of a hard synthetic resin or the like and has a substantially cylindrical shape. The guide member 36 is provided with a flange-shaped engagement portion 38 that protrudes toward the outer periphery at the front end. The base member 20 and the guide member 36 are connected in the axial direction by hooking the engagement projection 34 of the base member 20 onto the engagement portion 38. The engagement portion 38 of the guide member 36 is provided with locking hooks 40 as locking claws at two locations in the circumferential direction. The locking hooks 40 are integrally provided with a plate-shaped extension portion that extends rearward from the engagement portion 38 and a claw portion that protrudes from the tip of the extension portion toward the outer periphery. The rear surface of the locking hook 40 is inclined forward toward the outer periphery.

[0032] The diaphragm portion 18 is inserted into the inner periphery of this guide member 36. The clamping portion 22 of the diaphragm portion 18 is supported by being sandwiched between the base member 20 and the guide member 36 in the axial direction (front-rear direction), thereby assembling the diaphragm portion 18 to the base member 20 and the guide member 36. In this assembled state, the opening of the diaphragm portion 18 is liquid-tightly sealed by the base member 20 to form the sub-reservoir 14. Furthermore, the internal cavities of the drug solution inlet portion 30 and the drug solution outlet portion 32, which pass through the base member 20, are in communication with the internal space of the sub-reservoir 14.

[0033] The sub-reservoir 14 is positioned relative to the housing 12 by attaching the base member 20 and the guide member 36 to the housing 12. The bottom portion 24 of the diaphragm portion 18 is movable in the front-rear direction relative to the housing 12, and is permitted to expand and contract in the front-rear direction. The bulging deformation of the diaphragm portion 18 towards the periphery is restricted by the guide member 36.

[0034] Furthermore, a plunger 42 is superimposed on the bottom portion 24 of the diaphragm portion 18. As shown in Figs. 3 to 6, the plunger 42 has a structure in which a plunger main body 44 and an outer circumferential guide portion 46 are integrally connected at the rear end portion.

[0035] The plunger body 44 is generally cylindrical with a bottom that opens toward the rear. A fitting hole 48 that penetrates the center portion in the front-rear direction is formed in the front wall of the plunger body 44. The positioning protrusion 26 of the diaphragm portion 18 is fitted into this fitting hole 48, thereby forming a positioning mechanism that positions the plunger 42 and the bottom portion 24 of the diaphragm portion 18 relative to each other.

[0036] The outer periphery guide portion 46 is cylindrical and is provided so as to surround the outer periphery of the plunger body 44. The outer periphery guide portion 46 has two front end portions on its circumference each formed with an unlocking portion 50 that protrudes to the outer periphery. The unlocking portion 50 is inclined forward toward the outer periphery, and its inner periphery surface is an inclined surface. The unlocking portion 50 is inserted into an locking hole 58 of a push button 52, which will be described later. The unlocking portions 50, 50 are provided at positions corresponding to the locking hooks 40, 40 of the guide member 36 in the circumferential direction, and protrude to the outer periphery beyond the inner periphery surface of the locking hooks 40, 40.

[0037] The plunger 42 is inserted into a push button 52 as a pressing member. The push button 52 has a generally cylindrical shape with a bottom that opens forward. The opening of the push button 52 is inserted into the rear end of the housing 12 from the rear in the axial direction, and the push button 52 is assembled so as to be movable back and forth in the longitudinal direction (front-rear direction) of the housing 12. The bottom wall side of the push button 52 protrudes axially rearward from the rear end opening of the housing 12. The rear surface of the push button 52 exposed from the housing 12 is a pressing surface 54 as a fingertip pressing surface, and the patient, who is the user, can press the pressing surface 54 with his or her thumb while gripping the grip surface 16 of the housing 12.

[0038] A small-diameter cylindrical spring support portion 56 is integrally formed on the inner circumferential portion of the bottom wall of the push button 52. The spring support portion 56 has an outer circumferential shape that corresponds to the inner circumferential shape of a coil spring 60, which will be described later, and protrudes forward from the bottom wall of the push button 52.

[0039] Locking holes 58 are formed at two circumferential positions in the peripheral wall of the push button 52. The locking holes 58 penetrate the peripheral wall of the push button 52 in the radial direction and extend linearly in the front-rear direction.

[0040] A coil spring 60 is disposed between the plunger 42 and the push button 52 in the axial direction. The front end portion of the coil spring 60 is inserted into the inner circumference of the plunger body 44. The rear end portion of the coil spring 60 is inserted into the spring support portion 56 of the push button 52, and the coil spring 60 is positioned in the axial direction perpendicular to the push button 52. This allows the coil spring 60 to be stably held in a predetermined arrangement extending between the plunger 42 and the push button 52 in the front-rear direction. The plunger 42 and the push button 52 can be displaced relative to each other in the front-rear direction with the elastic deformation of the coil spring 60. The spring force of the coil spring 60 is applied between the plunger 42 and the push button 52. That is, when the coil spring 60 is compressed, a repulsive force based on the elasticity of the coil spring 60 is applied between the plunger 42 and the push button 52 in a direction that moves the plunger 42 and the push button 52 relatively away from each other.

[0041] An inflow flow path 62 and an outflow flow path 64 are connected to the base member 20 of the sub-reservoir 14, as shown in Fig. 3. The inflow flow path 62 can be switched from a communicating state to a blocked state by a shutoff valve 66. A restricting flow path 68 that bypasses the portion blocked by the shutoff valve 66 is connected to the inflow flow path 62, as shown in Figs. 3 and 5. The restricting flow path 68 has a smaller flow path cross-sectional area than the inflow flow path 62, so as to limit the flow rate (flow speed) of the medicinal liquid.

[0042] The outflow passage 64 can be switched between a communicating state and a blocked state by a rapid administration valve 70. The rapid administration valve 70 includes a valve body 72 for rapid administration and a coil spring 74 as a valve biasing means.

[0043] The valve body 72 is integrally provided with a valve body 76 and a pair of follower pieces 78, 78. As shown in FIG. 6, the valve body 76 has a plate-shaped clamp protrusion 80 that protrudes downward from the front-rear center portion and is provided so as to extend approximately perpendicular to the front-rear direction. The clamp protrusion 80 is gradually thinned toward the tip. The valve body 76 has a recess 81 opening on the upper surface, and the coil spring 74 is inserted into the recess 81. The coil spring 74 is compressed between the valve body 76 and the upper wall portion of the housing 12. As a result, a downward biasing force by the coil spring 74 acts on the valve body 76.

[0044] As shown in Figures 3 and 7, the pair of follower pieces 78, 78 of the valve body 72 are plate-shaped extending in the vertical direction. The lower surface of each follower piece 78 has a front portion that spreads perpendicularly to the vertical direction, and a rear portion that forms a follower-side inclined surface 82 that inclines upward toward the rear. The pair of follower pieces 78, 78 are disposed at a predetermined distance from each other in the left-right direction. A clamp protrusion 80 is provided between the pair of follower pieces 78, 78. The clamp protrusion 80 is formed integrally with the pair of follower pieces 78, 78, and both left and right ends are connected to the pair of follower pieces 78, 78.

[0045] A portion of the outflow passage 64 extends in the front-rear direction between the pair of follower pieces 78, 78, and a valve body 76 equipped with a clamp protrusion 80 is positioned above the outflow passage 64. A flow rate control section 84 that interconnects the inflow passage 62 and the outflow passage 64 is provided in front of the shutoff valve 66 and the rapid administration valve 70 in the inflow passage 62 and the outflow passage 64. The flow rate control section 84 has a smaller flow path cross-sectional area than the inflow passage 62 and the outflow passage 64, and is configured to limit the flow rate (flow speed) of the medicinal liquid.

[0046] The valve body 72 of the rapid administration valve 70 has a lower portion including a pair of driven pieces 78, 78 inserted into a cylindrical guide tube portion 86 extending upward from the bottom wall of the housing 12. This allows the valve body 72 to move up and down relative to the housing 12, while restricting movement in the front-rear and left-right directions. As shown in FIG. 7, the guide tube portion 86 has a through hole 88 that opens at the lower end of the peripheral wall. The through hole 88 is provided so as to penetrate the rear portion of the peripheral wall of the guide tube portion 86 in the front-rear direction. In this embodiment, a pair of through holes 88, 88 corresponding to a pair of contact pieces 92, 92 of the driving member 90 described later is formed.

[0047] The through hole 88 of the guide tube portion 86 allows the tip of the driving member 90 to be inserted therethrough. The driving member 90 is a hard member formed of synthetic resin such as polypropylene or polyamide, and is, for example, an injection-molded product of synthetic resin. As shown in Figs. 8 and 9, the driving member 90 has a pair of abutment pieces 92, 92 that face each other in the left-right direction and extend parallel to each other. The abutment piece 92 has a driving-side inclined surface 94 whose upper part on the front surface is inclined upward and backward. The pair of abutment pieces 92, 92 are connected to each other at their base ends by a main body portion 96. The main body portion 96 is provided with an input portion 98 that protrudes backward. The input portion 98 is in the form of a plate that curves and extends along the peripheral wall of the housing 12. In this embodiment, the driving member 90 is disposed at a position deviated to the right side in Fig. 3 from the center of the housing 12 in the left-right direction, so that the input portion 98 is inclined in the left-right direction.

[0048] As shown in Figs. 8 and 9, a return spring 100 is integrally formed with the main body 96 of the driving member 90. The return spring 100 is plate-shaped and elastically deformable in the front-rear direction. The return spring 100 extends forward from the front end of the main body 96 between the pair of abutting pieces 92, 92. The return spring 100 has a base end portion 102 connected to the main body 96 in a flat plate shape that inclines upward toward the front. The return spring 100 has an intermediate portion 104 extending from the base end portion 102 in a curved plate shape that is in an arc shape. The return spring 100 has a tip portion 106 extending from the intermediate portion 104 in a flat plate shape that inclines downward toward the front. The front end of the tip portion 106 of the return spring 100 is a free end and is located between the pair of abutting pieces 92, 92. The return spring 100 is elastically deformable by the deformation of the intermediate portion 104 so that the inclination angle between the base end portion 102 and the tip end portion 106 becomes smaller.

[0049] The driven member 90 is separate from the push button 52 and the valve body 72, and is disposed forward of the push button 52 as shown in Figs. 6 and 7. The thickness of the driven member 90 is greater than the thickness of the peripheral wall of the push button 52, so that the driven member 90 has high strength. A pair of abutment pieces 92, 92 of the driven member 90 are positioned at positions that allow insertion and removal in the front-rear direction with respect to the through holes 88, 88 of the guide tube portion 86. An input portion 98 of the driven member 90 is disposed at a position where at least a portion thereof overlaps with a front end portion 108 of the push button 52 in the front-rear direction. The front end of a tip portion 106 of the return spring 100 of the driven member 90 is positioned rearward of the pair of through holes 88, 88 of the guide tube portion 86.

[0050] In this way, the driven member 90 is a separate component independent of both the push button 52 and the housing 12 that includes the guide tube portion 86. Because the driven member 90 is separate from the push button 52, the components are prevented from becoming longer than when the driven member is provided integrally with the push button. Therefore, dimensional errors and distortions of the driven member 90 and the push button 52 are suppressed, and the rapid administration valve 70 can be switched between open and closed with high precision, and the driven member 90 and the push button 52 can be easily assembled to the housing 12.

[0051] The liquid injection controller 10 thus constructed constitutes a liquid administration device by connecting an upstream external line 110 to the inflow flow path 62 and a downstream external line 112 to the outflow flow path 64, as shown in Figs. 2 and 3. The upstream external line 110, the inflow flow path 62, the flow rate control unit 84, the outflow flow path 64, and the downstream external line 112 constitute a main line 114. The main line 114 is a flow path that connects a main reservoir (not shown) and an administration port (not shown) connected to an indwelling needle or the like on the patient side, without passing through the sub-reservoir 14. In addition, a sub-line 116 is constituted by the downstream side of the connection part of the flow rate control unit 84 in the inflow flow path 62 and the upstream side of the connection part of the flow rate control unit 84 in the outflow flow path 64. The sub-line 116 is a flow path that branches off from the main line 114 and is connected to the sub-reservoir 14.

[0052] In the liquid medicine injection controller 10 before use, the sub-reservoir 14 not filled with liquid medicine is contracted in the front-rear direction, as shown in, for example, FIGS. 3 to 6. The plunger 42 positioned at the bottom 24 of the sub-reservoir 14 is located forward. The push button 52 is located forward by the lock release parts 50, 50 of the plunger 42 being locked to the front end edges of the lock holes 58, 58. In the liquid medicine injection controller 10 before use, the plunger 42 and the push button 52 are located at relative positions farthest apart in the front-rear direction, and the amount of compression deformation of the coil spring 60 disposed between the plunger 42 and the push button 52 is small. Note that the push button 52 is located rearward of the lock hooks 40, 40 of the guide member 36, and the lock hooks 40, 40 are not inserted into the lock holes 58, 58.

[0053] In a drug solution administration device equipped with the drug solution injection controller 10, priming is performed before starting administration, in which the main line 114 and the sub-line 116 are filled with drug solution (priming solution). That is, in the initial state of the drug solution injection controller 10 (the state shown in Figs. 3 to 7) in which both the shutoff valve 66 and the rapid administration valve 70 are open, drug solution is fed from a main reservoir (not shown). As a result, the drug solution flow path including the main line 114 and the sub-line 116 and the sub-reservoir 14 are filled with drug solution. Then, air in the drug solution flow path and the sub-reservoir 14 is pushed downstream by the drug solution and discharged to the outside from an administration port (not shown) or the like.

[0054] Upon completion of priming, the sub-reservoir 14 is filled with the medicinal solution and becomes swollen, as shown in Fig. 10. As a result, the plunger 42 is pushed rearward by the diaphragm portion 18. The push button 52 moves rearward together with the plunger 42 and protrudes rearward from the rear end of the housing 12.

[0055] In a standby state where priming is complete and the push button 52 is not yet pressed, the front end 108 of the push button 52, which has moved rearward to the standby position, and the input portion 98 of the driven member 90 are separated from each other in the front-to-rear direction. As a result, a gap 118 is provided between the front end 108 of the push button 52 and the input portion 98 of the driven member 90. In other words, the driven member 90 is disposed across the gap 118 in the front-to-rear direction from the push button 52 in the standby position.

[0056] After priming is completed, the switch member 120 formed integrally with the stop valve 66 is pushed downward, causing the stop valve 66 integral with the switch member 120 to move downward. As a result, as shown in Figures 10 and 11, the stop valve 66 is pressed against the inflow passage 62 in a direction perpendicular to the passage, and the inflow passage 62 is crushed and blocked at the portion against which the stop valve 66 is pressed. The inflow passage 62 is connected by a restricting passage 68 on the upstream side and downstream side of the portion blocked by the stop valve 66, and the flow rate of the chemical solution per unit time is restricted by the restricting passage 68.

[0057] 11, the switch member 120 moves downward, and the engagement between the switch member 120 and the valve body 72 of the rapid administration valve 70 in the up-down direction is released, allowing the rapid administration valve 70 to move downward. This causes the valve body 72 to move downward by the biasing force of the coil spring 74, and the clamp protrusion 80 of the valve body 72 is pressed against the outflow flow passage 64 in a direction perpendicular to the outflow flow passage 64. As a result, as shown in FIGS. 10 to 12, the outflow flow passage 64 is partially crushed by the valve body 72, and the outflow flow passage 64 is partially blocked by the rapid administration valve 70, preventing the outflow of the medicinal liquid from the sub-reservoir 14.

[0058] When the valve body 72 of the rapid administration valve 70 moves downward, the pair of driven pieces 78, 78 are separated from the pair of abutment pieces 92, 92 of the driving member 90, as shown in Fig. 13. As a result, a gap 122 is formed between the pair of driven pieces 78, 78 and the pair of abutment pieces 92, 92. In other words, the driving member 90 is disposed across the gap 122 in the front-rear direction from the pair of driven pieces 78, 78 of the valve body 72, which is in the blocking position of the outflow passage 64. Therefore, the downward movement of the valve body 72 is not hindered by the driving member 90. Therefore, the blocking of the outflow passage 64 by the rapid administration valve 70 is realized without being hindered by the driving member 90.

[0059] However, even if the pair of driven pieces 78, 78 come into contact with the pair of abutment pieces 92, 92 of the driving member 90 during the downward movement of the valve body 72, the downward movement of the valve body 72 is not hindered by the driving member 90. In other words, the driving member 90 is permitted to move rearward because a gap 118 is formed between the front end portion 108 of the push button 52 and the input portion 98 of the driving member 90. Therefore, even if the pair of driven pieces 78, 78 come into contact with the pair of abutment pieces 92, 92 of the driving member 90, the driving member 90 moves rearward, so that the downward movement of the valve body 72 is permitted without being hindered by the driving member 90.

[0060] With the shutoff valve 66 and the rapid administration valve 70 closed, the medicinal liquid that has entered the inflow flow path 62 from the upstream external line 110 flows out through the flow control unit 84 to the downstream external line 112 connected to the outflow flow path 64. As a result, the medicinal liquid is continuously administered into the patient's body in small amounts through an indwelling needle (not shown) or the like that is connected to the main line 114 and the downstream external line 112. The amount of medicinal liquid per unit time that is continuously administered into the patient's body is regulated by the flow rate of the flow control unit 84.

[0061] When performing rapid administration to temporarily increase the amount of medicinal liquid administered, the patient performs a self-operation by pressing the push button 52 of the medicinal liquid injection controller 10. When the push button 52 is pressed by the patient, the coil spring 60 is compressed between the push button 52 and the plunger 42, as shown in Figure 14. As a result, a forward biasing force based on the elasticity of the compressed coil spring 60 is applied to the plunger 42.

[0062] When the push button 52 is pushed forward, the locking hooks 40 of the guide member 36 are inserted into the locking holes 58 of the push button 52 and are axially locked to the inner surfaces of the front ends of the locking holes 58. This holds the push button 52 in a pressed-in position against the biasing force of the coil spring 60, and the biasing force of the coil spring 60 is efficiently applied to the plunger 42.

[0063] When the push button 52 is pushed forward, the front end 108 of the push button 52 is pressed from behind against the input portion 98 of the driving member 90, as shown in Fig. 15. This causes the driving member 90 to move forward integrally with the push button 52, and the pair of abutment pieces 92, 92 of the driving member 90 are pressed against the pair of follower pieces 78, 78 of the valve body 72 of the rapid administration valve 70, as shown in Fig. 16. The pair of abutment pieces 92, 92 and the pair of follower pieces 78, 78 abut against each other at the driving side inclined surface 94 and the follower side inclined surface 82. Therefore, when a force input forward to the push button 52 is transmitted from the driving member 90 to the pair of follower pieces 78, 78, it is converted into an upward force and is applied to the valve body 72 having the pair of follower pieces 78, 78. As a result, the valve body 72 moves upward against the biasing force of the coil spring 74, and the blockage of the outflow passage 64 by the rapid administration valve 70 is released.

[0064] In the preparation state before the push button 52 is pressed, a gap 118 is formed between the front end 108 of the push button 52 and the input portion 98 of the driven member 90. Therefore, when the push button 52 is pressed, the front end 108 of the push button 52 and the input portion 98 of the driven member 90 approach each other from a separated state and come into contact with each other, generating an impact at the time of contact. Since the impact at the time of contact is transmitted to the patient's fingers operating the push button 52, the patient can also grasp the amount of pressing of the push button 52 from the tactile response. Furthermore, the patient can sense that the pressing operation of the patient is activating the medicinal liquid discharge mechanism from the tactile response transmitted to the fingers.

[0065] The amount of movement (movement stroke) by which the push button 52 and the driven member 90 move together while keeping the front end 108 and the input portion 98 in contact with each other is, for example, 1 / 5 or less, and more preferably 1 / 10 or less, of the entire stroke of the forward movement caused by pressing the push button 52. As a result, the impact caused when the push button 52 and the driven member 90 come into contact from a state in which they are separated by the gap 118 occurs after the push button 52 has moved to the end of its entire movement stroke. Therefore, the time from when the patient feels a response to when the pressing operation is completed is sufficiently short, and the patient can grasp from the response at an appropriate time that the pressing operation of the push button 52 is nearing completion.

[0066] In the preparation state before the pushing operation, a gap 122 is provided between the driving member 90 in the preparation position and the pair of driven pieces 78, 78 of the valve body 72. As a result, when the pair of abutment pieces 92, 92 of the driving member 90 come into contact with the pair of driven pieces 78, 78 of the valve body 72, the impact of the contact is transmitted to the fingers of the patient operating the push button 52. Therefore, the patient who pushes the push button 52 can understand from the tactile response that the driving member 90 has pushed up the valve body 72 and moved to a position where it releases the blockage of the outflow flow path 64 by the rapid administration valve 70.

[0067] As the driving member 90 advances relative to the housing 12, the return spring 100 of the driving member 90 is pressed against the guide tube portion 86 of the housing 12 between the pair of through holes 88, 88 and elastically deforms. As a result, a rearward biasing force, which is a direction returning the driving member 90 to the initial position, is applied to the driving member 90, which is in a position advanced from the initial position, based on the elasticity of the return spring 100.

[0068] When the push button 52 is pressed and the coil spring 60 is compressed, the plunger 42 is pressed against the diaphragm portion 18 of the sub-reservoir 14 by the biasing force of the coil spring 60. As a result, the bottom portion 24 of the diaphragm portion 18 is pushed forward by the plunger 42. As a result, the internal pressure of the sub-reservoir 14 pressed by the plunger 42 increases, and the medicinal liquid stored in the sub-reservoir 14 flows out to the downstream external line 112 through the outflow flow path 64 that is in a connected state. Then, the amount of medicinal liquid administered to the patient's body through the downstream external line 112 increases temporarily, and rapid administration of the medicinal liquid is performed. Note that the inflow flow path 62 is blocked by the closing valve 66, and the inner cavity of the restricting flow path 68 is made extremely small. Therefore, when the internal pressure of the sub-reservoir 14 increases, the medicinal liquid in the sub-reservoir 14 is sent to the outflow flow path 64 without flowing back to the inflow flow path 62.

[0069] In this way, the push button 52 pressed by the user does not directly press the plunger 42 to transmit force, but compresses the coil spring 60 between it and the plunger 42. The repulsive force of the compressed coil spring 60 is then exerted on the plunger 42, causing the plunger 42 to press against the sub-reservoir 14. This makes it possible to prevent an excessively large compressive force from acting on the sub-reservoir 14, improving the durability of the sub-reservoir 14 and enabling the drug solution in the sub-reservoir 14 to be efficiently pushed out.

[0070] Once the push button 52 is pressed, the liquid injection controller 10 keeps the push button 52 in the pressed position until administration of the liquid medicine is completed. Therefore, by performing a single short pressing operation, substantially the entire amount of the liquid medicine stored in the sub-reservoir 14 is administered over a predetermined period of time. Therefore, a patient using the liquid injection controller 10 can administer a sufficient amount of liquid medicine with a single push, without having to keep pressing the push button 52.

[0071] In this embodiment, the plunger 42 and the bottom 24 of the diaphragm portion 18 are positioned relative to each other by the positioning protrusion 26. Therefore, when the diaphragm portion 18 of the sub-reservoir 14 is compressed by the movement of the plunger 42, the displacement of the compression position is prevented, and the diaphragm portion 18 is compressed stably.

[0072] 17, when rapid administration of the medicinal liquid is completed, the locking release portions 50, 50 of the plunger 42, which has moved forward, come into contact with the locking hooks 40 of the guide member 36, bending the locking hooks 40 inward to the left and right. This releases the locking of the locking hooks 40, 40 with the inner surfaces of the locking holes 58, 58 of the push button 52, allowing the push button 52 to move backward relative to the housing 12.

[0073] A force based on the elasticity of the return spring 100 acts rearward on the push button 52 and the driven member 90. Therefore, when the restriction on the movement of the push button 52 by the locking hooks 40, 40 is released, the push button 52 and the driven member 90 quickly move rearward to a position where the return spring 100 returns to its initial shape (see FIG. 3). When the push button 52 is released from the locking hooks 40, 40, the push button 52 moves rearward due to the elasticity of the return spring 100, causing the locking hooks 40, 40 to come out of the locking holes 58, 58 and position themselves forward of the push button 52.

[0074] The driven member 90 moves linearly in the forward and backward direction, which is the same direction as the reciprocating movement direction of the push button 52. This makes it possible to reduce the size of the liquid injection controller 10 in the direction perpendicular to the forward and backward direction, which is the reciprocating movement direction of the push button 52. Note that the movement direction of the driven member 90 being the same as the reciprocating movement direction of the push button 52 does not only mean the case where they are strictly the same direction, but also includes a direction that is inclined relative to the direction that can be regarded as being substantially the same direction.

[0075] Furthermore, the return spring 100 of this embodiment is formed integrally with the driving member 90. Therefore, the number of parts can be reduced compared to a structure in which a return spring is provided separately from the driving member 90, and the structure can be simplified.

[0076] The return spring 100 is given a predetermined elasticity by having the intermediate portion 104 in a curved and bent plate shape. Therefore, while the driving member 90 is made of a hard material, the return spring 100 formed integrally with the driving member 90 is given elasticity. In this way, the driving member 90 formed integrally with the return spring 100 is made hard, and the shape stability of the driving member 90 is ensured, thereby ensuring the accuracy of the switching operation of the rapid administration valve 70.

[0077] When the push button 52 moves rearward, the lock release portions 50, 50 of the plunger 42 are locked to the inner surfaces of the locking holes 58, 58 of the push button 52, so that the plunger 42 moves rearward together with the push button 52.

[0078] When the driving member 90 moves rearward due to the elasticity of the return spring 100, the pair of abutment pieces 92, 92 of the driving member 90 is released from contact with the pair of driven pieces 78, 78 of the valve body 72 constituting the rapid administration valve 70. As a result, the clamp projection 80 of the valve body 72 is pressed against the outflow passage 64 by the biasing force of the coil spring 74, and the outflow passage 64 is switched to a blocked state by the rapid administration valve 70. In this way, due to the elastic force of the return spring 100 acting on the driving member 90, the outflow passage 64 is quickly and stably blocked by the rapid administration valve 70 when the rapid administration of the medicinal solution is completed.

[0079] Furthermore, by moving the push button 52 backward, a portion of the medicinal liquid sent from the main reservoir (not shown) to the upstream external line 110 is filled into the sub-reservoir 14 through the inflow flow path 62 and the restriction flow path 68. Note that the time required for the sub-reservoir 14 to be refilled with a predetermined amount of medicinal liquid after rapid administration of the medicinal liquid is adjusted by the restriction flow path 68, and by preventing an excessive supply of medicinal liquid to the sub-reservoir 14, overadministration of the medicinal liquid is prevented.

[0080] As the amount of medicinal liquid in the sub-reservoir 14 increases, the plunger 42 is pushed backward by the diaphragm portion 18 of the sub-reservoir 14. Then, the sub-reservoir 14 is filled with substantially the same amount of medicinal liquid as before rapid administration, and the plunger 42 and the push button 52 are moved to the preparation positions before rapid administration of medicinal liquid is performed, as shown in Figure 10. This makes it possible to perform rapid administration of medicinal liquid by the user again.

[0081] As shown in Fig. 1, a protrusion 124 provided on the plunger 42 is inserted into a slit 126 penetrating the peripheral wall of the housing 12 as a marker. The axial position of the plunger 42 relative to the housing 12 can be grasped from the outside based on the position of the protrusion 124 in the slit 126. For example, a state in which the upper protrusion 124 has moved to the vicinity of the rear end of the slit 126 indicates a state in which the sub-reservoir 14 is filled with the drug solution. The plunger 42 of this embodiment has a rotationally symmetric shape of 180° in the circumferential direction, and the orientation restrictions are relaxed when assembling the plunger 42, which facilitates manufacturing.

[0082] Although the embodiment of the present invention has been described in detail above, the present invention is not limited to the specific description. For example, the gap 122 provided between the pair of abutment pieces 92, 92 of the driving member 90 and the pair of follower pieces 78, 78 of the valve body 72 is not essential. In the preparation position before the push button 52 is pressed, the pair of abutment pieces 92, 92 of the driving member 90 and the pair of follower pieces 78, 78 of the valve body 72 may be in contact with each other.

[0083] The driving member 90 does not necessarily have to have only a pair of abutment pieces 92, and may have a structure having one or three or more abutment pieces 92. The number of follower pieces 78 of the valve body 72 may also be one or three or more. The number of the abutment pieces 92 and the number of the follower pieces 78 may be different from each other. The type, configuration, shape, etc. of the valve body are not limited in the present invention.

[0084] The return spring may be separate from the driven member. Specifically, for example, a return spring made of an elastic body such as a coil spring or rubber may be disposed as a separate member between the driven member and the guide tube portion, thereby providing a separate return spring from the driven member. In this way, if the driven member and the return spring are separate, the materials and shapes of the driven member and the return spring can be set with a large degree of freedom according to the different characteristics required for the driven member and the return spring. [Explanation of symbols]

[0085] 10: chemical injection controller, 12: housing, 14: sub-reservoir, 52: push button (push operation member), 64: outflow flow path, 72: valve body, 90: driving member, 100: return spring

Claims

1. A housing that accommodates a cup-shaped sub-reservoir having a peripheral wall and a bottom, and a pressing member for performing rapid drug administration is assembled so as to be capable of reciprocating movement in the housing, a plunger is provided which is actuated via a spring when the pressing operation member is pressed to press the sub-reservoir, and the plunger is positioned in a superposed relationship with the bottom of the sub-reservoir; The plunger is provided with a mark that allows the position of the plunger in the reciprocating direction to be visually observed from outside the housing; A drug solution injection controller in which the peripheral wall and the bottom of the sub-reservoir are formed as a single unit, including a protrusion formed on the bottom for positioning the plunger.

2. The positioning protrusion is fitted into a fitting hole formed in the plunger and positioned, A coil spring is disposed between the pressing member and the plunger, 2. The liquid injection controller according to claim 1, wherein the positioning protrusion fitted into the fitting hole of the plunger at one end of the coil spring abutted against the plunger is positioned protruding from the inner circumference of the coil spring.

3. The bottom of the sub-reservoir is thicker than a peripheral wall of the sub-reservoir, When the pressing operation member is pressed, the bottom of the sub-reservoir is maintained in a state of being overlapped with the plunger, 3. The chemical liquid injection controller according to claim 1, wherein a central portion of the bottom of the sub-reservoir is curved convexly toward the inside of the sub-reservoir.

4. The positioning protrusion is fitted into a fitting hole formed in the plunger and positioned, The positioning protrusion has a tapered tip portion and a step formed on the base end side of the tapered tip portion, 4. The liquid injection controller according to claim 1, wherein the step is engaged with the fitting hole.

Citation Information

Patent Citations

  • Chemical self-injector and chemical self-injection system

    JP2007111179A

  • Self-administration device for liquid medicine

    JP2010227144A

  • Patients with lockouts Self-administered drug high-dose bolus dispenser

    JP2016536052A

  • Bolus drug delivery device

    US20160074575A1

  • Bolus delivery device

    WO2018226317A1